All In Biotech

NDA 020475 · Bausch

Retin-A-Micro

Tretinoin · Topical · Retinoid

Last checked: Nov 20, 2026Latest source record: Sep 10, 2025 (newest FDA action)Source: Drugs@FDA, openFDA, CMS, ClinicalTrials.gov, PubMedMethods & limitations

First approved

1997

Feb 7, 1997

Approved uses

2

Original approval plus efficacy supplements

Registered trials

375

82 Phase 3, 25 recruiting

FAERS reports

6,689

4,179 serious, 854 with death reported

AI brief across all sources

Written by AI from the FDA, CMS, ClinicalTrials.gov, FAERS and PubMed data on this page, plus web searches for pricing, exclusivity and pending FDA decisions.

What it is approved for

From the label in effect Sep 30, 2025.

Tretinoin Gel Microsphere is indicated for the topical treatment of acne vulgaris in adults and pediatric patients 12 years of age and older. Tretinoin Gel Microsphere is a retinoid indicated for the topical treatment of acne vulgaris in adults and pediatric patients 12 years of age and older. ( 1 )

Mechanism: Although tretinoin activates three members of the retinoic acid (RAR) nuclear receptors (RARα, RARβ, and RARγ) which may act to modify gene expression, subsequent protein synthesis, and epithelial cell growth and differentiation, it has not been established whether the clinical effects of tretinoin are mediated through activation of retinoic acid receptors and/or other mechanisms. The exact mechanism of action of topical tretinoin for treatment of acne vulgaris is unknown. Current evidence suggests that topical tretinoin decreases cohesiveness of follicular epithelial cells with decreased...

Therapeutic areas: Ophthalmology

Approval history

Original approval and efficacy supplements (new uses, populations or doses), newest first, with FDA's letters and labels.

  • May 10, 2002 Supplement 8 · Efficacy LetterLabel
  • Feb 7, 1997 Original approval · Type 3 - New Dosage Form Review
4 products under this application
  • RETIN-A-MICRO · TRETINOIN 0.06% · GEL, TOPICAL · Prescription · TE AB
  • RETIN-A MICRO · TRETINOIN 0.04% · GEL, TOPICAL · Prescription
  • RETIN-A-MICRO · TRETINOIN 0.08% · GEL, TOPICAL · Prescription · TE AB
  • RETIN-A MICRO · TRETINOIN 0.1% · GEL, TOPICAL · Prescription

Clinical trials

Interventional ClinicalTrials.gov studies with "Tretinoin" as an intervention, any sponsor and status, largest first.

All 375 trials

Most reported adverse reactions

FAERS reports naming this application or brand. Unverified reports, not rates; a report can name several drugs.

Signals
  • off label use889
  • drug ineffective746
  • pain498
  • product use in unapproved indication485
  • vomiting452
  • paraesthesia374
  • abdominal pain upper368
  • rash366
  • nausea354
  • diarrhoea352
  • headache339
  • maternal exposure during pregnancy339

FAERS reports by year

By the date FDA received the report.

View as table
YearReports
200439
200533
200624
200740
2008118
200975
201082
2011102
2012165
2013107
2014149
2015236
2016357
2017371
2018466
2019364
2020384
2021428
2022513
2023573
2024681
2025815
2026567

Recalls

0 FDA enforcement reports for this application.

No recalls on record for this application.

Shortages

FDA's drug shortage list.

Not on FDA's shortage list.

Medicare spending

CMS Spending by Drug. Part D is pharmacy-dispensed; Part B is given in a clinic or hospital outpatient setting. Spending is before manufacturer rebates.

Compare

Part D: Retin-A Micro (Tretinoin Microspheres)

2024 spending

$14K

Beneficiaries

16

19 claims

Per beneficiary

$879

$15.80 per unit

View as table
YearSpending
2020$230,185
2021$235,185
2022$233,856
2023$187,415
2024$14,062

Published evidence

PubMed clinical trials, meta-analyses and systematic reviews, most relevant first.

All 420 on PubMed

Sponsor: Bausch · Also marketed as Retin-A Micro

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.